To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02847559
Title Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Northwestern University
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
John Wayne Cancer Center at Providence St. John's Health Center COMPLETED Santa Monica California 90404 United States Details
Miami Cancer Institute COMPLETED Miami Florida 33176 United States Details
Piedmont Healthcare COMPLETED Atlanta Georgia 30309 United States Details
Northwestern University RECRUITING Chicago Illinois 60611 United States Details
Northwestern University- Lake Forest Hospital ACTIVE_NOT_RECRUITING Lake Forest Illinois 60045 United States Details
Northwestern Medicine/ Cadence Health - CDH RECRUITING Winfield Illinois 60190 United States Details
Vidant Medical Center, East Caroling University ACTIVE_NOT_RECRUITING Greenville North Carolina 27834 United States Details
University of Pennsylvania RECRUITING Philadelphia Pennsylvania 19104 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field